187 related articles for article (PubMed ID: 8679157)
21. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
Park K; Park HJ; Chun YM
Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
[TBL] [Abstract][Full Text] [Related]
22. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
Bujia J; Kim C; Ostos-Aumente P; Lopez-Villarejo J; Kastenbauer E
Eur Arch Otorhinolaryngol; 1997; 254(1):6-8. PubMed ID: 9115708
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
25. The c-MYC protooncogene expression in cholesteatoma.
Palkó E; Póliska S; Csákányi Z; Katona G; Karosi T; Helfferich F; Penyige A; Sziklai I
Biomed Res Int; 2014; 2014():639896. PubMed ID: 24683550
[TBL] [Abstract][Full Text] [Related]
26. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
Liu D; Ma X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
[TBL] [Abstract][Full Text] [Related]
27. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
Caffier PP; Marzahn U; Franke A; Sudhoff H; Jovanovic S; Haisch A; Sedlmaier B
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1179-88. PubMed ID: 18253741
[TBL] [Abstract][Full Text] [Related]
28. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
Kim HJ; Tinling SP; Chole RA
J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
[TBL] [Abstract][Full Text] [Related]
30. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
Kojima H; Shiwa M; Kamide Y; Moriyama H
Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of tenascin in cholesteatoma and external auditory meatal skin compared to retroauricular epidermis.
Schilling V; Lang S; Rasp G; Mack B; Nerlich A
Acta Otolaryngol; 1996 Sep; 116(5):741-6. PubMed ID: 8908253
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical investigations on external auditory canal cholesteatomas.
Adamczyk M; Sudhoff H; Jahnke K
Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
Li H; Jiang P; Wang L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
[TBL] [Abstract][Full Text] [Related]
35. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
Huang CC; Chen CT; Huang TS; Shinoda H
Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
[TBL] [Abstract][Full Text] [Related]
36. Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma.
Bayazít YA; Karakök M; Uçak R; Kanlíkama M
Laryngoscope; 2001 Jun; 111(6):1037-41. PubMed ID: 11404617
[TBL] [Abstract][Full Text] [Related]
37. Expression of human intercellular adhesion molecules in middle ear cholesteatoma.
Bujía J; Holly A; Kim C; Scanady N; Kastenbauer E
Am J Otolaryngol; 1994; 15(4):271-5. PubMed ID: 7526720
[TBL] [Abstract][Full Text] [Related]
38. Expression of annexin II in human middle ear cholesteatoma.
Kim TT; Chen CT; Huang CC
Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):324-8. PubMed ID: 9527111
[TBL] [Abstract][Full Text] [Related]
39. Survival signaling and terminal differentiation in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
Park K; Chun YM; Park HJ; Lee YD
Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
